- 8.4 percent reduction for patients with any diagnosis
- 10.1 percent reduction for congestive heart failure patients
- 12.0 percent reduction for acute myocardial infarction patients
Abbott Labs completed the acquisition of St. Jude Medical in January.
Insiders at these companies -- including Tailored Brands and Qualcomm -- have been scooping up shares of their own stock lately.
Abbott Labs is one of four names to own.